SCHEMBL4756368

SCHEMBL4756368

C1=Nc2cc3c4c(ccc3nc2=N1)=CC=N4

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8121239 0.63
SCHEMBL30728052 0.56
SCHEMBL29546936 0.54
SCHEMBL5619234 0.53
SCHEMBL32683621 0.52
SCHEMBL7408468 0.50
SCHEMBL7962744 0.49
SCHEMBL27882713 0.48
SCHEMBL2045014 0.48
SCHEMBL6643717 0.47 CYP19A1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114621225-A Imidazopyridoindole compound and preparation method and application thereof 石河子大学 2022-06-14 CN claimed
EP-0018857-B1 PYRIMIDO AND IMIDAZO-PYRIDO-INDOLE-DIONES, THEIR PREPARATION AND THERAPEUTIC USE SYNTHELABO (FR) 1983-01-19 EP claimed
EP-0018857-A1 Pyrimido and imidazo-pyrido-indole-diones, their preparation and therapeutic use SYNTHELABO (FR) 1980-11-12 EP claimed
CN-114621225-A Imidazopyridoindole compound and preparation method and application thereof 石河子大学 2022-06-14 CN disclosed
CN-114621225-A Imidazopyridoindole compound and preparation method and application thereof 石河子大学 2022-06-14 CN disclosed
EP-1390367-B1 DIHYDROIMIDAZO 5,1-A -$G(b)-CARBOLINE DERIVATIVES, METHOD FOR PREPARING SAME AND USE THEREOF AS MEDICINE MACEF (FR) 2008-07-09 EP disclosed
US-20080096909-A1 APOMORPHINE INHIBITORS OF AMYLOID-BETA (ABETA) FIBRIL FORMATION AND THEIR USE IN AMYLOIDOSIS BASED DISEASE CYTOKINE PHARMASCIENCES, INC. (US) 2008-04-24 US disclosed
US-7291627-B2 Dihydroimidazo[5.1-a]-beta-carboline derivatives, method for their preparation, and their application as a drug MACEF (FR) 2007-11-06 US disclosed
US-20060089372-A1 Dihydroimidazo[5,1-a]sg(b)-carboline derivatives, method for preparing same and use thereof as medicine MACEF (FR) 2006-04-27 US disclosed
EP-1390367-A1 DIHYDROIMIDAZO 5,1-A]-$G(b)-CARBOLINE DERIVATIVES, METHOD FOR PREPARING SAME AND USE THEREOF AS MEDICINE MACEF (FR) 2004-02-25 EP disclosed
US-20030187011-A1 Apomorphine inhibitors of amyloid-beta (Abeta) fibril formation and their use in amyloidosis based disease CYTOKINE PHARMASCIENCES, INC. 2003-10-02 US disclosed
WO-2003053356-A2 APOMORPHINE INHIBITORS OF AMYLOID-β (Aβ) FIBRIL FORMATION AND THEIR USE IN AMYLOIDOSIS BASED DISEASE CYTOKINE PHARMASCIENCES, INC. (US) 2003-07-03 WO disclosed
WO-2002092598-A1 DIHYDROIMIDAZO [5,1-A]-$G(b)-CARBOLINE DERIVATIVES, METHOD FOR PREPARING SAME AND USE THEREOF AS MEDICINE MACEF (FR) 2002-11-21 WO disclosed
US-4358451-A ANOXIA, PSYCHOTROPIC SYNTHELABO (FR) 1982-11-09 US disclosed
US-4358451-A ANOXIA, PSYCHOTROPIC SYNTHELABO (FR) 1982-11-09 US disclosed
US-4358451-A ANOXIA, PSYCHOTROPIC SYNTHELABO (FR) 1982-11-09 US disclosed
EP-0018857-A1 Pyrimido and imidazo-pyrido-indole-diones, their preparation and therapeutic use SYNTHELABO (FR) 1980-11-12 EP disclosed